Skip to main content

Table 3 Differentiating neuroendocrine tumors with immunohistochemical markers

From: Pitfalls in the management of subglottic paragangliomas at unusual location: a case report and literature review

Immunohistochemical

markers

Paraganglioma

Typical carcinoid

Atypical carcinoid

Small cell neuroendocrine tumor

MTC

FTC

1.Neuro-specific enolase

(+)

(+)

(+)

(+)

(+)

(−)

2.Chromogranin A

(+)

(+)

(+)

(+)

(+)

(+)

3.Synaptophysin

(+)

(+)

(+)

(+)

(+)

(−)

4.Glial fibrillary acidic protein*

(+)

(−)

(−)

(−)

(+)

(−)

5.S-100 protein*

(+)

(−)

(−)

(−)

(−)

(−)

6.Cytokeratin

(−)

(+)

(+)

(+)

(+)

(+)

7.Calcitonin

(−)

(+)

(+)

(+)/(−)

(+)

(+)

8.CEA

(−)

(+)

(+)

(+)

(+)

(+)

9.EMA

(−)

(+)

(+)

(+)

(+)

(+)

10. TTF1

(−)

(−)

(−)

(+)/(−)

(+)

(+)

11. MIB-1

(−)

(−)

(−)

(−)

(−)

(+)

  1. MTC medullary thyroid carcinoma; FTC follicular thyroid carcinoma; CEA carcinoembryonic antigen; EMA epithelial membrane antigen; TTF-1 thyroid transcription factor 1; MIB-1 molecular immunology Borstel number 1
  2. *Positivity only in the sustentacular cells